Ferry endosomal RAB5 effector complex subunit 4

CRYZL1 (also known as Ferry endosomal RAB5 effector complex subunit 4 or Fy-4) is a 349-amino acid protein that functions as a component of the FERRY complex, a five-subunit endosomal assembly involved in RAB5A-mediated intracellular signaling (UniProt: O95825). The FERRY complex directly interacts with mRNAs and the small GTPase RAB5A to regulate the localization and distribution of specific mRNAs, facilitating their transport to early endosomes through direct mRNA binding and ribosome recruitment (UniProt: O95825).

This protein participates in endosomal trafficking pathways critical for cellular communication and cargo organization. No UniProt-curated disease associations are currently documented for CRYZL1, though its role in mRNA transport suggests potential relevance to processes dependent on precise subcellular localization of transcripts.

In Alzheimer's disease, CRYZL1 is significantly downregulated in post-mortem AD brain tissue compared to age-matched controls, with a mean log2 fold-change of −1.01 (Chaparral AD proteomics). This reduction was detected via TMT-labeled mass spectrometry across multiple subcellular fractions, suggesting impaired endosomal mRNA trafficking may contribute to AD pathology.